may, 2018
may, 2018
08mayAll DayICER Open Comments Due
Final patient input for the new CGRP medications must be emailed to ICER at publiccomments@icer-review.org by Tuesday, May 8. For more information, see
Final patient input for the new CGRP medications must be emailed to ICER at publiccomments@icer-review.org by Tuesday, May 8. For more information, see Updated Patient Input Guide from the Headache & Migraine Policy Forum.
All Day (Tuesday)
#N/A
Many new medicines and devices have been approved over the past few years for the treatment of headache, migraine, and cluster diseases. Pharmaceutical companies and device manufacturers are currently offering financial assistance programs to help cover costs and get these new treatments into the hands of patients. The details for each program varies. To help you navigate, CHAMP created Financial Assistance Guides that provide easy-to-understand information, whether you have private or public insurance or are uninsured.
CHAMP has multiple resources to guide you along the map of your patient journey. From our Language and Image Guide to our Financial Assistance Guides we are here to help.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Close Window